Tacrolimus ointment |
Protopic |
Tacrolimus Systematic (IUPAC) name 3S-[3R*[E(1S*,3S*,4S*)] ,4S*,5R*,8S*,9E,12R*,14R*,15S*,16R*,18S*,19S*,26aR*]] -5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a -hexadecahydro-5, 19-dihydroxy -3-[2-(4-hydroxy-3-methoxycyclohexyl) -1-methylethenyl]-14,16-dimethoxy -4,10,12,18-tetramethyl-8-(2-propenyl) -15,19-epoxy-3H-pyrido[2,1-c][1,4] oxaazacyclotricosine-1,7,20,21(4H,23H) -tetrone, monohydrate Identifiers CAS number 104987-11-3 ATC code L04AA05 D11AX14 PubChem 656830 D ...
Wikipedia - [full article]
Tacrolimus ointment Clinical Trials
- Topical Tacrolimus 0.03% Ointment for Intractable Allergic Conjunctivitis: An Open Label Pilot Study
ClinicalTrials.gov Identifier: NCT00443105 - Active, not recruiting
Allergic Conjunctivitis
- A Multi-Center Study of Short and Long-term Use of Protopic Ointment in Patients with Atopic Dermatitis
ClinicalTrials.gov Identifier: NCT00106496 - Completed
Dermatitis, Atopic
- Tacrolimus and Mycophenolate Mofetil (MMF) in GVHD Prophylactic Regimen Compared to Tacrolimus and Methotrexate (MTX
ClinicalTrials.gov Identifier: NCT00360685 - Recruiting
Mucositis; Graft-Versus-Host Disease
- Preventing Staphylococcal (Staph) Infection
ClinicalTrials.gov Identifier: NCT00108160 - Recruiting
Staphylococcal Infections
- Tacrolimus and Daclizumab Versus Tacrolimus and Steroids in Liver Recipients Receiving Sub-Optimal Grafts
ClinicalTrials.gov Identifier: NCT00321074 - Recruiting
Liver Transplantation
- Effects of Immunosuppression on HCV Recurrence After Living Donor Liver Transplantation - Comparative Study Between Tacrolimus + MMF and Tacrolimus + Steroid
ClinicalTrials.gov Identifier: NCT00469131 - Recruiting
Hepatitis C; Liver Cirrhosis
- Comparative Study of Modified Release (MR) Tacrolimus/MMF in de novo Kidney Transplant Recipients
ClinicalTrials.gov Identifier: NCT00064701 - Active, not recruiting
Kidney Transplantation
- Total-Body Irradiation, Tacrolimus, and Mycophenolate Mofetil Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancers
ClinicalTrials.gov Identifier: NCT00003572 - Active, not recruiting
Leukemia; Lymphoma; Multiple Myeloma
- Clinical Trial to Assess the Efficacy and Safety of Tacrolimus Ointment Treatment of Atopic Dermatitis in Adult Patients
ClinicalTrials.gov Identifier: NCT00523952 - Completed
Dermatitis, Atopic
- Topical SB-275833 Ointment, 1% For The Treatment Of Impetigo
ClinicalTrials.gov Identifier: NCT00133874 - Recruiting
Impetigo
- Tacrolimus Ointment Long Term Safety in Young Children With Atopic Dermatitis
ClinicalTrials.gov Identifier: NCT00560326 - Completed
Dermatitis, Atopic
- Efficacy and Safety Assessment of Cyclosporine Microemulsion C2 Monitoring Versus Tacrolimus C0 Monitoring in De Novo Liver Transplant Recipients
ClinicalTrials.gov Identifier: NCT00149994 - Active, not recruiting
Liver transplant
- Mycophenolate Mofetil, Tacrolimus, Daclizumab, and Donor Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
ClinicalTrials.gov Identifier: NCT00006350 - Active, not recruiting
Leukemia; Lymphoma; Multiple Myeloma
- Comparison of Alemtuzumab/Tacrolimus Versus Interleukin-2 Receptor (IL-2R) Monoclonal Antibody (MoAb)/Tacrolimus/Mycophenolate in Kidney Transplantation
ClinicalTrials.gov Identifier: NCT00246129 - Recruiting
Kidney Transplantation; Kidney Diseases; Kidney Failure
- AIRSAC Trial - Comparison of a Tacrolimus/Sirolimus/Prednisone Regimen Versus Tacrolimus/Azathioprine/Prednisone Immunosuppressive Regimen in Lung Transplantation
ClinicalTrials.gov Identifier: NCT00321906 - Recruiting
Delayed Graft Function; Graft Rejection
- Safety and Efficacy of Converting Maintenance Kidney and Liver Transplant Recipients with Abnormal Glucose Metabolism from Tacrolimus to Cyclosporine Micro-Emulsion
ClinicalTrials.gov Identifier: NCT00150085 - Active, not recruiting
Tacrolimus-associated abnormal glucose metabolism in kidney and liver transplant recipients
- Etanercept with Tacrolimus for Psoriasis
ClinicalTrials.gov Identifier: NCT00134394 - Active, not recruiting
Psoriasis
- Treatment and Control of Atopic Dermatitis With 0.03% Tacrolimus Ointment
ClinicalTrials.gov Identifier: NCT00480896 - Completed
Dermatitis, Atopic
- Immunosuppression with Campath-1H and Tacrolimus in Liver Transplantation
ClinicalTrials.gov Identifier: NCT00105235 - Active, not recruiting
Liver Transplantation
- Sirolimus/Tacrolimus Versus Tacrolimus/Methotrexate for Preventing Graft-Versus-Host Disease (GVHD)
ClinicalTrials.gov Identifier: NCT00406393 - Recruiting
Leukemia, Myelocytic, Acute; Leukemia, Lymphocytic, Acute; Leukemia, Myeloid, Chronic; Myelodysplastic Syndromes
- Treatment and Control of Atopic Dermatitis With 0.1% Tacrolimus Ointment
ClinicalTrials.gov Identifier: NCT00480610 - Completed
Dermatitis, Atopic
- Tacrolimus Ointment Pharmacokinetics in Infants With Atopic Dermatitis
ClinicalTrials.gov Identifier: NCT00535691 - Completed
Dermatitis, Atopic
- Tacrolimus for the Treatment of Systemic Lupus Erythematosus With Membranous Nephritis
ClinicalTrials.gov Identifier: NCT00125307 - Active, not recruiting
type V (membranous) lupus nephritis
- Enteric-Coated Mycophenolate Sodium (EC-MPS) With Reduced-Dose Tacrolimus Versus EC-MPS With Standard-Dose Tacrolimus in Stable Kidney Transplant Recipients
ClinicalTrials.gov Identifier: NCT00284934 - Recruiting
Kidney Diseases
- MQX-503 vs Nitroglycerin Ointment: A Pharmacokinetic Comparison in Normal Subjects
ClinicalTrials.gov Identifier: NCT00513994 - Active, not recruiting
Healthy
- Tacrolimus: Protocol FKC-009 - Canadian Cardiology De Novo Study
ClinicalTrials.gov Identifier: NCT00157014 - Active, not recruiting
Heart transplantation; Cardiac transplantation; Transplantation, Cardiac; Transplantation, Heart; Grafting, Heart
- Reduction of Tacrolimus Dose in Association with Mycophenolate Mofetil After Liver Transplantation.
ClinicalTrials.gov Identifier: NCT00151632 - Recruiting
Liver Transplantation
- Prevention of the Graft-Versus-Host-Disease in Patients After Stem Cell Transplantation with Tacrolimus and Everolimus
ClinicalTrials.gov Identifier: NCT00117702 - Recruiting
Graft vs Host Disease
- Treatment Of Impetigo With Topical SB-275833 Ointment, 1% Versus Topical Placebo Ointment
ClinicalTrials.gov Identifier: NCT00133848 - Completed
Impetigo
- Use of Sirolimus vs. Tacrolimus For African-American Renal Transplant Recipients
ClinicalTrials.gov Identifier: NCT00252655 - Active, not recruiting
Kidney Transplantation
- Study of Myfortic in Combination With Tacrolimus and Thymoglobulin in Early Corticosteroid Withdrawal
ClinicalTrials.gov Identifier: NCT00374803 - Active, not recruiting
Kidney Transplant
- Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Ointment in Patients With Psoriasis Vulgaris
ClinicalTrials.gov Identifier: NCT00248456 - Active, not recruiting
Psoriasis Vulgaris
- An Evaluation of the Efficacy, Safety, Preference and Duration of Response of Clobex (Clobetasol Propionate) Spray vs. Taclonex (Calcipotriene 0.005%/ Betamethasone Dipropionate 0.064%) Ointment in Subjects With Stable Plaque Psoriasis
ClinicalTrials.gov Identifier: NCT00437255 - Active, not recruiting
Psoriasis
- Efficacy and Safety of AEB071 Plus Tacrolimus (Converted to Mycophenolic Acid After 3 Months), in Renal Transplant Patients
ClinicalTrials.gov Identifier: NCT00403416 - Active, not recruiting
Kidney Transplantation
- Fludarabine and Melphalan Followed by Tacrolimus and Methotrexate in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Relapsed Lymphoma
ClinicalTrials.gov Identifier: NCT00121186 - Active, not recruiting
adult Hodgkin''s lymphoma; adult non-Hodgkin''s lymphoma
- Phase I/II Study of Pentostatin Combined With Tacrolimus and Mini-Methotrexate for GVHD Prevention After MUD BMT
ClinicalTrials.gov Identifier: NCT00506922 - Active, not recruiting
Leukemia; Lymphoma
- Retapamulin Ointment in Healthy Adults Nasally Colonized With Staphylococcus Aureus
ClinicalTrials.gov Identifier: NCT00539994 - Recruiting
Nasal Colonization
- Study of Unrelated Cord Blood Transplantation Using Tacrolimus and Sirolimus
ClinicalTrials.gov Identifier: NCT00133367 - Recruiting
Multiple Myeloma; Non-Hodgkin''s Lymphoma; Hodgkin''s Disease; Myelogenous Leukemia; Lymphoblastic Leukemia
- The Pharmacokinetics of Sirolimus When Combined With Cyclosporine or Tacrolimus in Renal Transplant Patients
ClinicalTrials.gov Identifier: NCT00166816 - Active, not recruiting
Transplantation; Kidney Transplantation; Immunosuppression
- Tacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation
ClinicalTrials.gov Identifier: NCT00096096 - Active, not recruiting
childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Graft Versus Host Disease; hematopoietic and lymphoid cancer
- Evaluation of Cyclosporine Microemulsion and Tacrolimus on the Rate of New Onset Diabetes Mellitus in Kidney Transplantation Recipients
ClinicalTrials.gov Identifier: NCT00171496 - Active, not recruiting
Kidney Transplant
- A Study of a Modified-Release Tacrolimus Based Immunosuppression Regimen in Stable Pediatric Liver Transplant Patients
ClinicalTrials.gov Identifier: NCT00282256 - Active, not recruiting
Liver Transplantation
- Efficacy and Safety of Calcipotriol Cream and (Calcipotriol + Betamethasone Dipropionate) Ointment in Psoriasis Vulgaris
ClinicalTrials.gov Identifier: NCT00216892 - Active, not recruiting
Psoriasis Vulgaris
- Sirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematologic Cancer Who are Undergoing Donor Stem Cell Transplantation
ClinicalTrials.gov Identifier: NCT00089037 - Active, not recruiting
childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Graft Versus Host Disease; hematopoietic and lymphoid cancer
- A Study to Assess the Pharmacokinetics of a Modified-Release Tacrolimus Based Immunosuppression Regimen in Stable Liver Transplant Patients
ClinicalTrials.gov Identifier: NCT00282243 - Active, not recruiting
Liver Transplantation
- A Study to Assess the Pharmacokinetics of a Modified-Release Tacrolimus Based Immunosuppression Regimen in Stable Kidney Transplant Patients
ClinicalTrials.gov Identifier: NCT00282568 - Active, not recruiting
Kidney Transplantation
- Alemtuzumab, Tacrolimus, and Methylprednisolone in Treating Acute Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant
ClinicalTrials.gov Identifier: NCT00109993 - Active, not recruiting
Breast Cancer; Endocrine Cancer; female reproductive cancer; Graft Versus Host Disease; hematopoietic and lymphoid cancer; Neuroblastoma
- Phase III, Long-Term, Open-Label, Extension Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal Keratoconjunctivitis
ClinicalTrials.gov Identifier: NCT00567918 - Active, not recruiting
Keratoconjunctivitis; Conjunctivitis
- A Study of Thymoglobulin and Tacrolimus in Liver Transplant
ClinicalTrials.gov Identifier: NCT00564538 - Enrolling by invitation
Liver Transplantation; Liver Disease; Immunosuppression
- Nitroglycerin Ointment for Preventing Bone Loss in Postmenopausal Women
ClinicalTrials.gov Identifier: NCT00043719 - Completed
Osteoporosis; Osteopenia
- The Effect of Sirolimus on the Pharmacokinetics of Tacrolimus
ClinicalTrials.gov Identifier: NCT00166829 - Recruiting
Kidney Transplantation
- Interaction Between Rimonabant and Cyclosporine and Tacrolimus
ClinicalTrials.gov Identifier: NCT00525681 - Recruiting
Renal Transplantation
- A Study to Determine the Effect of Nitroglycerin Ointment on the Pain Associated With Chronic Anal Fissures
ClinicalTrials.gov Identifier: NCT00522041 - Recruiting
Fissure in Ano; Pain
- Comparing Efficacy & Safety of Tacrolimus With/Without MMF or Monoclonal Anti-IL2R Antibody in Liver Transplantation.
ClinicalTrials.gov Identifier: NCT00295594 - Active, not recruiting
Liver Transplantation
- To Compare the Efficacy and Safety of a Therapy of Tacrolimus With Sirolimus or MMF in Kidney Transplantation.
ClinicalTrials.gov Identifier: NCT00296361 - Active, not recruiting
Kidney Transplantation
- A Pilot Study for the Efficacy and Safety of Tacrolimus in the Treatment of Refractory Lupus Nephritis
ClinicalTrials.gov Identifier: NCT00569101 - Active, not recruiting
Lupus Nephritis
- Pharmacokinetic Study on the Combination of Everolimus-Tacrolimus
ClinicalTrials.gov Identifier: NCT00325325 - Recruiting
Kidney Diseases
- Evaluation of 20% Betulinic Acid Ointment for Treatment of Dysplastic Nevi (Moderate to Severe Dysplasia)
ClinicalTrials.gov Identifier: NCT00346502 - Recruiting
Dysplastic Nevus Syndrome
- Prednisone and Either Cyclosporine or Tacrolimus With or Without Mycophenolate Mofetil in Treating Patients With Newly Diagnosed Chronic Graft-Versus-Host Disease
ClinicalTrials.gov Identifier: NCT00089141 - Recruiting
Cancer; Graft Versus Host Disease
- Comparing Efficacy and Safety of Tacrolimus With Steroids or Monoclonal Anti-IL2R Antibody in Hepatitis C Virus (HCV) Positive Liver Transplant Patients
ClinicalTrials.gov Identifier: NCT00295607 - Active, not recruiting
Hepatitis C; Liver Transplantation
- An Open Label Six Month Study to Evaluate the Safety and Efficacy of Nitrogen Mustard (NM) 0.04% Ointment Formulation in Patients With Stage I or IIA Mycosis Fungoides (MF) Who Have Completed an Initial 12 Month Treatment With Nitrogen Mustard 0.02% But W
ClinicalTrials.gov Identifier: NCT00535470 - Enrolling by invitation
Mycosis Fungoides
- MGA031, Sirolimus and Tacrolimus in Islet Transplantation
ClinicalTrials.gov Identifier: NCT00265473 - Recruiting
Type 1 Diabetes Mellitus; Hypoglycemia
- Effectiveness and Safety of Campath in Combination with Tacrolimus Monotherapy to Prevent Kidney Graft Rejection
ClinicalTrials.gov Identifier: NCT00147381 - Active, not recruiting
Kidney Transplantation
- Clinical Study to Evaluate the Tolerability, Safety and Efficacy of Enteric-Coated Mycophenolate Sodium, After Equimolar Conversion From Mycophenolate Mofetil (MMF), in Patients With Stable Renal Transplant Receiving Tacrolimus
ClinicalTrials.gov Identifier: NCT00171392 - Active, not recruiting
Prevention of Acute Rejection After Kidney Transplantation
- Safety/Efficacy of Induction Agents with Tacrolimus, MMF, and Rapid Steroid Withdrawal in Renal Transplant Recipients
ClinicalTrials.gov Identifier: NCT00113269 - Active, not recruiting
Kidney Transplantation
- Comparing Efficacy & Safety of Tacrolimus & MMF With/Without Induction in the Elderly Following Kidney Transplantation.
ClinicalTrials.gov Identifier: NCT00296309 - Active, not recruiting
Kidney Transplantation
- Safety and Effectiveness Study of an Experimental Topical Ointment (GS-9191) for the Treatment of Genital Warts
ClinicalTrials.gov Identifier: NCT00499967 - Recruiting
Genital Warts
- Evaluation of Topical 10% Metronidazole Ointment for the Treatment of Active Perianal Crohn's Disease
ClinicalTrials.gov Identifier: NCT00509639 - Recruiting
Crohn's Disease
- Comparison of Two Tacrolimus Based Immunosuppressive Regimens in Recipients Receiving Marginal Donor Kidneys
ClinicalTrials.gov Identifier: NCT00321113 - Recruiting
Kidney Transplantation
- Efficacy and Safety of Sirolimus in Combination with Tacrolimus
ClinicalTrials.gov Identifier: NCT00141804 - Active, not recruiting
Kidney Transplantation
- Bortezomib Plus Tacrolimus and Methotrexate to Prevent GVHD After Mismatched Allogeneic Non-Myeloablative Blood Stem Cell Transplantation
ClinicalTrials.gov Identifier: NCT00369226 - Recruiting
Hematologic Malignancies
- Steroid Withdrawal in Pediatric Kidney Transplant Recipients
ClinicalTrials.gov Identifier: NCT00023244 - Active, not recruiting
End-Stage Renal Disease
- Tacrolimus and Sirolimus as Prophylaxis After Allogenic Non-Myeloablative Peripheral Blood Stem Cell Transplantation
ClinicalTrials.gov Identifier: NCT00282282 - Recruiting
Graft Versus Host Disease; GVHD
- Suppressing the Immune System With or Without Steroids in Children Who Have Received Kidney Transplants
ClinicalTrials.gov Identifier: NCT00141037 - Active, not recruiting
Kidney Diseases; Kidney Transplantation
- Investigation in Myositis-Associated Pneumonitis of Prednisolone And Concomitant Tacrolimus
ClinicalTrials.gov Identifier: NCT00504348 - Recruiting
Interstitial Pneumonitis; Polymyositis; Dermatomyositis
- Comparison of Sirolimus to Tacrolimus for Long Term Therapy in Kidney Transplant With No Steroids
ClinicalTrials.gov Identifier: NCT00170053 - Recruiting
Kidney Diseases
- TACrolimus in Renal Transplantation: Individualization by Pharmacogenetic
ClinicalTrials.gov Identifier: NCT00552201 - Recruiting
Kidney Transplantation
- The Comparison of Tacrolimus and Sirolimus Immunosuppression Based Drug Regimens in Kidney Transplant Recipients
ClinicalTrials.gov Identifier: NCT00275535 - Recruiting
Kidney Diseases
- Combination Therapy to Prevent Kidney Transplant Rejection
ClinicalTrials.gov Identifier: NCT00078559 - Active, not recruiting
Kidney Transplantation
- 5% Lidocaine Ointment in the Treatment of Vulvar Vestibulitis
ClinicalTrials.gov Identifier: NCT00450242 - Recruiting
Vulvar Vestibulitis
- Islet Cell Transplants for Diabetes
ClinicalTrials.gov Identifier: NCT00014911 - Active, not recruiting
Diabetes Mellitus, Insulin-Dependent
- A Study of BMS-224818 (Belatacept) in Patients Who Have Undergone a Kidney Transplant and Are Currently on Stable Cyclosporine or Tacrolimus Regimen With or Without Corticosteroids
ClinicalTrials.gov Identifier: NCT00402168 - Recruiting
Renal Transplant
- Conversion From Tacrolimus to Cyclosporine Microemulsion in Liver Transplant Patients With New Onset Diabetes After the 3rd Month Post-Transplant
ClinicalTrials.gov Identifier: NCT00171717 - Active, not recruiting
Maintenance Liver Transplant Patients With New Onset Diabetes
- Combination Chemotherapy, Tacrolimus, and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant For Hematologic Cancer
ClinicalTrials.gov Identifier: NCT00134017 - Recruiting
childhood Hodgkin''s lymphoma; childhood non-Hodgkin''s lymphoma; chronic myeloproliferative disorders; Leukemia; Lymphoma; plasma cell neoplasm
- Pre-Transplant Assessment of Tacrolimus Blood Level Concentration, as a Predictor of Tacrolimus Dose Requirements After Kidney Transplantation
ClinicalTrials.gov Identifier: NCT00297310 - Completed
Kidney Transplantation; Transplantation
- A Safety and Efficacy Study of Prograf in the Prevention of Erectile Dysfunction after Radical Prostatectomy
ClinicalTrials.gov Identifier: NCT00106392 - Active, not recruiting
Erectile Dysfunction; Prostate Cancer
- Early Conversion From Tacrolimus to Efalizumab Maintenance Therapy in Kidney Transplant Recipients
ClinicalTrials.gov Identifier: NCT00472082 - Recruiting
Kidney Transplantation; Chronic Kidney Failure
- Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous or Acute Leukemia
ClinicalTrials.gov Identifier: NCT00002831 - Active, not recruiting
Leukemia, Myeloid; Leukemia, Myeloid, Chronic
- Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who are Undergoing Donor Stem Cell Transplant for Hematologic Cancer
ClinicalTrials.gov Identifier: NCT00105001 - Recruiting
childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Graft Versus Host Disease; hematopoietic and lymphoid cancer
- Comparing Efficacy and Safety of Steroid Withdrawal With Tacrolimus and MMF With Induction in Children After Kidney Transplantation
ClinicalTrials.gov Identifier: NCT00296348 - Recruiting
Kidney Transplantation
- Liver Fibrosis in Patients Transplanted for Hepatitis C Receiving Either Cyclosporine Microemulsion or Tacrolimus
ClinicalTrials.gov Identifier: NCT00260208 - Recruiting
Liver Transplant; Hepatitis C
- To Compare the Efficacy of Tacrolimus and Mycophenolate Mofetil for the Initial Therapy of Active Lupus Nephritis
ClinicalTrials.gov Identifier: NCT00371319 - Recruiting
Lupus; Nephritis
- Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplantation for Hematologic Cancer
ClinicalTrials.gov Identifier: NCT00089011 - Recruiting
childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Graft Versus Host Disease; hematopoietic and lymphoid cancer
- This Study is Designed to Evaluate Whether Tacrolimus Dose Reduction in de Novo Renal Recipients Receiving Everolimus Can Preserve Renal Function While Maintaining Efficacy.
ClinicalTrials.gov Identifier: NCT00369161 - Recruiting
Renal Transplantation
- A Trial to Assess Campath-1H and Tacrolimus Followed by Immunosuppression Withdrawal in Liver Transplantation
ClinicalTrials.gov Identifier: NCT00166556 - Recruiting
Transplantation, Liver
- Tacrolimus (FK506) P-III Placebo-Controlled Double-Blind Study in Moderate to Severe Refractory Ulcerative Colitis Patients
ClinicalTrials.gov Identifier: NCT00347048 - Recruiting
Ulcerative Colitis
- Combining Chemotherapy, Tacrolimus, Mycophenolate Mofetil, and Radiation Therapy with Donor Bone Marrow Transplantation in Treating Patients with Hematologic Cancer
ClinicalTrials.gov Identifier: NCT00049504 - Recruiting
childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Leukemia; Lymphoma; myelodysplastic and myeloproliferative diseases; ...
- Polymorphism of the Cytochrome P450-System and the MDR-System in Renal Transplants Receiving the Immunosuppressive Drugs Tacrolimus, Sirolimus, Everolimus or Cyclosporine A
ClinicalTrials.gov Identifier: NCT00223054 - Recruiting
Renal Transplantation
- Comparison of the Two Immunosuppressive Regimens Based on Tacrolimus and Cyclosporine Following Kidney Transplantation
ClinicalTrials.gov Identifier: NCT00204191 - Recruiting
Kidney Transplantation
- Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed By Donor Bone Marrow Transplant and Cyclophosphamide, Mycophenolate Mofetil, and Tacrolimus in Treating Patients With Immunodeficiency or Noncancerous Inherited Disorders
ClinicalTrials.gov Identifier: NCT00358657 - Recruiting
Precancerous/Nonmalignant Condition
Resources
- Protopic (Drug Digest)
- Tacrolimus ointment (Drug Digest)

Not Signed In -

